SESSION TOPICS

---

Microbiome 101

Speaker: Neil Stollman, MD (UCSF)

Objective: Become familiar with the human gut microbiome and its role in health.

Evidence of efficacy and safety of FMT for C. difficile infection

Speaker: Colleen Kelly, MD (Brown)

Objective: Review evidence from randomized controlled trials of FMT in C. difficile.

Unique Challenges Around Clinical Trials in C. difficile

Speaker: Paul Feuerstadt, MD (Yale)

Objective: Describe unique challenges to conducting clinical trials of microbiome-based therapies in C. difficile.

Taming the Wild West: Developing Standards for Microbiome Research and Product Development

Speaker: Scott Jackson, PhD (NIST)

Objective: Describe the importance of standards for microbiome measurements to support research investigations and clinical/commercial translation of microbiome science.

Detection of SARS-CoV-2 from patient fecal samples by WGS

Speaker: Andreas Papoutsis, PhD (ProgenaBiome)

Objective: Understand methods used to study the composition and function of the gut microbiome and identification of SARS-CoV-2.

Microbiome and Disease associations (cause or consequence)?

Speaker: Sabine Hazan, MD (ProgenaBiome)

Understand the value of genetic sequencing in fecal transplant and in SARS-CoV-2 therapies.

Microbiome based Therapies for Recurrent Urinary Tract Infections

Speaker: Sahil Khanna, MD (Mayo Clinic)

Objective: Examine the role of microbiome based therapy in chronic UTI.

Microbiota Transplant for Autism

Speaker: James B. Adams, PhD (Arizona State University)

Objective: Review a Phase 1 clinical trial of microbiota transplant for children with autism.

Management of Immunotherapy Induced Colitis

Speaker: Yinghong Wang, MD, PhD (MD Anderson)

Objective: Describe how gut microorganisms impact the metabolism of cancer therapies and how microbial manipulation may transform patient care.

Serendipity and Fecal Transplant

Speaker: Thomas Borody, MD (CDD Australia)

Objective: Explore Fecal transplant for other conditions beyond C.difffocusing on Crohn’s and neurological conditions.

Washed microbiota transplantation: Treatment beyond C.diffinfection

Speaker: Faming Zhang MD, PhD (Nanjing Medical University, Nanjing, China)

Objective: Describe the latest progress on methodology, safety and benefits related to FMT in conditions beyond C.diffinfection,

How do we move forward?

Speaker: Alexander Khoruts, MD (University of Minnesota)

Objective: Understand the challenges in doing research to develop and make available the next-generation microbiota therapeutics for different indications?

Panel Discussions,  Announcements, and more!